RPC(SZ:000650) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-11-13 23:20Core Viewpoint - The controlling shareholder, Renhe (Group) Development Co., Ltd., plans to reduce its stake in Renhe Pharmaceutical Co., Ltd. due to its own development needs, intending to sell up to 3,000,000 shares, which represents 0.2143% of the company's total share capital [2][5]. Shareholder Holding Situation - As of the announcement date, Renhe (Group) Development Co., Ltd. holds 325,299,386 shares of the company, accounting for 23.2367% of the total shares [2]. Reduction Plan Details - The reduction plan will be executed within three months starting from 15 trading days after the announcement date, through centralized bidding or block trading methods [2][3]. - The number of shares to be reduced will be adjusted if there are changes in the company's capital structure, such as stock dividends or capital increases, but the proportion of the total share capital will remain unchanged [2][4]. Compliance and Commitments - Renhe (Group) Development Co., Ltd. has fulfilled its previous commitments regarding share trading restrictions, which were in place for 36 months after the shares became tradable [4][5]. - The current reduction plan does not conflict with any previously disclosed intentions or commitments [5].